Website features 'Rollercoaster' on home page

Online mag, forallevents.com, names 'Rollercoaster' as its current book of the month

"Rollercoaster: How a man can survive his partner's breast cancer," has been named "Book of the Month" by an online magazine.

Thanks to Joseph Cillo, publisher/editor-in-chief of forallevents.com, the website is featuring the book I, Woody Weingarten, have aimed at male caregivers (husbands, boyfriends, fathers, sons and brothers) of patients.

The book is a guide to research, meds and where to get help — as well as a chronicle-memoir and a love story.

Just click on http://forallevents.com and then on the book cover on the magazine's home page to find out more about what I have to say.

The site's stated goal is to promote "choices for a more personally satisfying and fulfilling lifestyle — new and interesting events, destinations, travel, cuisine, beverages, culture and products."

Thanks, Joe, your endorsement is greatly appreciated.

Aging increase causes spread of medical facilities

What's behind boom in cancer centers across U.S.? Answer: 'silver tsunami' and money

A cancer center building boom is spreading across the country, according to a story this week in the Washington Post by Brady Dennis.

The piece reports the American Cancer Society as saying "more than 1.6 million people in the United States will be diagnosed with cancer this year," and goes on to suggest "the number is certain to rise with the aging of the baby boom generation."

A steady population increase among the elderly means "a push to bring the latest specialized treatments and access to more clinical trials to patients who don't live near major academic research centers," the article states.

Voila! The national building boom.

Furthermore, the piece notes that because "medical advances are allowing more people to live longer with cancer and, in some case, to treat it as a chronic disease…there is fierce competition among hospitals searching for reliable revenue in a rapidly changing health-care landscape."

There remain many skeptics in the medical community, however, those who contend the label cancer center can easily be applied by virtually any facility and, therefore, "doesn't guarantee that each place will have doctors with deep expertise, a track record of good outcomes or credentials such as a National Cancer Institute designation as a top-notch center."

Dr. Peter Bach

Daniels' article quotes, for instance, Dr. Peter Bach, an oncologist and director of the Center for Health Policy and Outcomes at New York's famed Memorial Sloan Kettering Cancer Center.

Bach, whose wife, Ruth, died a few years back when her breast cancer recurred and metastasized, says his concern is that an average patient could have difficulty determining where to get "high-quality care when the market is flooded with places claiming to be cancer centers."

The Washington Post piece also says that "it remains unclear whether the proliferation of cancer centers…will lead to more tests, surgeries and mediations being billed to Medicare, private insurers and patients."

An outgrowth of the rise in the aging population, according to the story, is that well-known institutions — such as Sloan Kettering or Baltimore's Johns Hopkins — "are forming alliances with smaller hospitals in an effort to extend their brands, in some cases around the country and the globe."

The Post quotes Patrick Duke, managing director for a consulting group that advises hospitals about real estate projects, CBRE Healthcare, to the effect that the economics of cancer treatment "are good. That's a touchy subject for some people, but it's the reality…The procedures and the drugs are well reimbursed. It's a big business."

Is the boomer concept real?

Seven years ago, when I, Woody Weingarten, served on the Marin County Civil Grand Jury, I was repeatedly told our area was being inundated by a "silver tsunami." The truth of that became evident as I opened my eyes and saw who was driving on our highways, walking on our streets.

Clearly, the longer folks last, the greater chance there is for them to contract a life-threatening disease. My VitalityPress book, "Rollercoaster: How a man can survive his partner's breast cancer," whose aim is helping male caregivers, discusses the aging population, medical care in general and breast cancer care in particular, and high medical costs.

Shh! Don't talk of how docs, hospitals mess up

N.Y. lawyers argue for easing legislation and regulations that stifle malpractice suits

Malpractice suits are something hospital execs and physicians prefer no one talk about, especially in public.

But two attorneys took to the op-ed page of The New York Times this week to argue for a change in New York state law to lengthen the time in which lawsuits can be filed.

Thomas Moore

The pair, partner Thomas Moore and associate Steve Cohen of the firm Kramer, Dillof, Livingston and Moore, also maintained that "as long as hospitals and doctors block legislation and fight regulation, patients will remain in peril."

Their jumping off point, according to their opinion piece, was a futile legislative attempt to update a state law that allows victims only two and a half years "from the time of the medical mistake in which to bring an action, not from the time the error was discovered or should have been discovered" — the latter being the standard in 44 of the nation's 50 states.

The lawyers also asserted that "hospitals are dangerous places," noting that in 1999 "the Institute of Medicine at the National Academy of Sciences published a study…which concluded that at least 44,000 patients were killed (and many more injured) in hospitals each year because of medical errors. By 2011, a study in the journal HealthAffairs estimated that the number of avoidable deaths was probably 10 times higher."

The attorneys, whose agenda clearly would line their own pockets, went on to claim that "doctors and hospitals are doing a poor job of policing themselves, yet they have been successful at keeping anyone else from doing it."

As might be expected, opposition to extending the statute of limitations came from the hospital and health care lobby, whose agenda is equally one-sided.

The KDL&M website cites the firm's success "in medical malpractice cases, labor law and negligence cases," and notes that it's won "more than 120 verdicts of over $1 million" and "negotiated settlements on behalf of their clients in excess of $1 billion."

I, Woody Weingarten, discuss medical silences and malpractice possibilities in "Rollercoaster: How a man can survive his partner's breast cancer," a VitalityPress book particularly aimed at male caregivers.

Study's data splits docs over one-dose treatment

Risk of recurrence is debated because of less costly radiation therapy that's easier to take

Should a breast cancer patient opt for radiation that costs less and is more convenient when it might double or triple the small risk of recurrence?

That's what's currently being debated in the medical community regarding those in the early stages of the disease.

According to a story last week in the Wall Street Journal by Melinda Beck, a single dose of intra-operative radiation therapy, usually shortened to IORT, normally is given while lumpectomy surgery is happening.

The procedure reportedly has fewer side effects than conventional radiation with treatments that last five days a week for five to seven weeks.

Critics, the story says, claim a study shows the risk of recurrence in women treated with IORT is 3.3% rather than 1.3% over a five-year period.

But critics of the critics say the risk is small and worth it — and some point to a potential conflict of interest because many radiation centers take in huge amounts of revenue through the extended treatments.

Dr, Anthony Zietman

According to the article, Dr. Anthony Zietman, radiation oncologist at Boston's Massachusetts General and a Harvard professor, wrote an editorial in the International Journal of Radiation Oncology this month that said a single treatment, "depending on your perspective…is either a significant threat or a quantum leap forward."

The cancer industry debate has intensified because of the release of data stemming from the Cleveland Clinic study of 1,000 patients who've undergone IORT at 19 U.S. centers. 

Radiation has allowed lumpectomies to surpass mastectomies in popularity, with 60 percent of new patients now choosing the former. But its side effects include fatigue, skin blistering and, although infrequently, damage to hearts, legs and rib cages.

Because elongated radiation "can be disruptive for women who work, care for children or live far from radiation," Beck's article says, "about one-third of women who begin radiation don't finish their prescribed courses, studies show."

IORT started in Europe in the late 1990s but has grown in acceptance, with 260 medical centers worldwide now offering the treatment.

Want to know more about lumpectomy versus mastectomy, or about radiation treatments? Check out "Rollercoaster: How a man can survive his partner's breast cancer," the VitalityPress book I, Woody Weingarten, aimed at husbands, boyfriends, fathers, sons and brothers who are caregivers.

Is chemical a link to cancers, birth defects?

Huffington Post exposé looks at possibility that DuPont corp. actually poisoned the planet

Almost everyone agrees that environmental toxins contribute to the fact that 250,000 women are diagnosed with breast cancer each year.

And that those environmental factors most likely lead to countless men and women contracting other cancers.

As well as birth defects.

Now comes a Huffington Post exposé well worth a look-see, a revelatory piece about DuPont's actions regarding it allegedly poisoning the planet with a chemical compound innocuously called C8.

Some may find the story, comprehensive (and long), too depressing. 

Others may be inspired to protest one thing or another.

Some may even defend DuPont, whose ads have used the trademarked phrase "The miracles of science" with its logo, by invoking an old chestnut, sometimes erroneously attributed to Calvin Coolidge: "What's good for business is good for the country."

Regardless, the piece may shake your faith in the idea that only the bottom line — profit — counts.

In my new VitalityPress book, "Rollercoaster: How a man can survive his partner's breast cancer," which is aimed at male caregivers, I, Woody Weingarten, discuss a variety of environmental factors and how they might — or might not — be responsible for the disease. 

Study questions value of post-Stage O procedures

Women with D.C.I.S. must weigh breast cancer surgeries against doing nothing at all

Karen Jaggar

Women who get a lumpectomy or a mastectomy after developing ductal carcinoma in situ, or D.C.I.S., an early form of breast cancer, don't necessarily increase their chances of living.

That's the conclusion of a new, extensive study of 100,000 women followed for 20 years, according to a story in The New York Times by the newspaper's cancer expert, Gina Kolata.

Patients with this condition, also called Stage O, apparently had a 3.3 percent of dying within 20 years of the treatment, regardless of the procedure they underwent — similar to an average woman's chance of dying of breast cancer.

JAMA Oncology cited the researchers' findings yesterday, Aug. 20, basing them on what the Times labeled "the most extensive collection of data ever analyzed on this condition."

D.C.I.S. involves abnormal cells confined to the breast's milk ducts. Upwards of 60,000 women a year are diagnosed with it.

It is generally agreed in the cancer care community that unnecessary and disfiguring treatments following D.C.I.S. diagnosis have often been excessive, but only a minority of physicians believe the best way to treat the condition is to do nothing.

Kolata's story quoted one leading doctor as believing D.C.I.S. "should be treated as a precursor to potentially deadly invasive cancers, analogous to colon polyps that can turn into colon cancer." 

Karen Jaggar, executive director of an educational organization based in San Francisco, Breast Cancer Action, was quoted in the piece as saying women tend not to appreciate the harms of over-treatment and often over-estimate their risk of dying of cancer, "making them react with terror."

As always, though, this study may quickly be contradicted by new studies already underway. "Rollercoaster: How a man can survive his partner's breast cancer," the VitalityPress book I, Woody Weingarten, wrote mainly for male caregivers, details how researchers and physicians can flip-flop "on a dime" about almost any medical decision.

'90210' star blames metastasis on insurance lapse

Actress Shannen Doherty battling breast cancer — and ex-managers, for it spreading

Shannen Doherty

Shannen Doherty, who gained fame by starring in TV's "Beverly Hills, 90210" but even more from fighting with her co-stars, is now fighting again.

This time it may be for her life.

She's been diagnosed with breast cancer.

The 44-year-old's also battling her ex-business managers and accountants — via a court suit — for allegedly mismanaging her money and letting her health insurance lapse, an action that in turn purportedly allowed the cancer to spread.

Doherty, who's also starred in television's "Charmed," may require a mastectomy and chemotherapy.

According to an Associated Press story in USA Today and other newspapers, she apparently has been unable to work since her March diagnosis, which was just revealed through the lawsuit.

The suit maintains the metastasis has caused her "severe emotional distress," the story adds.

Doherty also has incurred "significant medical expenses," People magazine said later.

According to the Daily Dish, the actress claimed "she paid bosses at Tanner, Mainstain, Glynn & Johnson five percent of her earnings to manage her finances, including medical insurance payments to the Screen Actors Guild, and when they ignored a bill, her coverage was canceled for much of 2014."

That cancellation, she charges, forced her not to visit her doctor for regular check-ups, only to find subsequently she had breast cancer that has since metastasized.

An earlier diagnosis, she says, might have resulted in treatments that could have stopped the cancer from spreading.

She contends that an earlier diagnosis might have resulted in treatments that could have stopped the cancer from spreading.

A lawyer for the firm, Randall J. Dean, called her claim "patently false."

Doherty's husband, Kurt Iswarienko, also is suing the Tanner, Mainstain for mismanaging the couple's money, thereby "leading to other financial troubles, including tax audits and liens," the AP reported.

Want to know what ups and downs Iswarienko, a photographer, is facing as Doherty's prime caregiver? 

In a VitalityPress book,  "Rollercoaster: How a man can survive his partner's breast cancer," I, Woody Weingarten, address what male caregivers can do to help their mates and themselves.

Sandra Lee out of hospital after new operation

Infection forces longtime Food Network star to undergo new breast surgery in New York

Spirited Sandra Lee in hospital.

Sandra Lee, Food Network star for more than a decade, has undergone a new surgery following complications from her recent double mastectomy.

News and gossip media immediately ran photos of her — alongside her longtime live-in partner, New York Gov. Andrew Cuomo — giving a thumbs-up sign as she left the New York hospital Wednesday, Aug. 12, a day after the two-hour surgery.

"Everything went well," said Cuomo, "so it's all good."

Cuomo, who's been Lee's boyfriend for a decade, has assumed the role of prime caregiver, one with which I, Woody Weingarten, author of "Rollercoaster: How a man can survive his partner's breast cancer," am totally familiar.

Staffers had reported on Facebook earlier that she seemed "to be back to herself" in the hospital, "rearranging flowers on the table, cleaning countertops and organizing seating for her visitors."

Facebook post: Sandra Lee, Andrew Cuomo.

Lee had explained on Facebook that she chose the new surgery when a painful fluid buildup and infection followed the original operation.

She called the infection an "incredible monster," and said she'd done everything possible "to avoid"  the second operation — including modern Western, Eastern and holistic treatments.

Just before her release, her staff wrote that Lee was "up and energized" to go home. Her recovery, they indicated, would probably involve intravenous infusions because she need "massive antibiotics for a couple of weeks to fight against infection."  

Lee, a Daytime Emmy winner who's released 25 books (including a memoir), apparently will need nursing care during that time.

The 49-year-old, known for her show, “Semi-Homemade Cooking with Sandra Lee,” which premiered on the Food Network in 2003, underwent her first operation in May after being diagnosed with breast cancer.

Lee, whose second cable show, "Sandra's Money Saving Meals," debuted in 2009, also noted on Facebook that “I am a long way from where I was and a long way from where I need to be, but at this point I understand that right now I just need to complete this unexpected phase of a tough journey.”